Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 12311-12320 Newer>

The Motley Fool February 8, 2006 Stephen D. Simpson	Pepsi: It's the Snacks Good performance across the board keeps this one nice and bubbling. But the stock trades above its fair value. Investors may want to look elsewhere.
The Motley Fool February 8, 2006 W.D. Crotty	Best Blue Chip: ExxonMobil In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: ExxonMobil is the best of this bunch -- and its products fuel the industrialized world.
The Motley Fool February 8, 2006 Nathan Slaughter	Best Blue Chip: Johnson & Johnson In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: it is easy to see why Johnson & Johnson, deserves to carry home the gold.
The Motley Fool February 8, 2006 Rick Aristotle Munarriz	Best Blue Chip: Coca-Cola In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: Coca-Cola is bold, cold, and oh so worthy of that gold.
The Motley Fool February 8, 2006 Nathan Parmelee	Best Blue Chip: Altria In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: There are many reasons to dislike Altria, but stock performance is not one of them.
The Motley Fool February 8, 2006 Tim Beyers	Best Blue Chip: GE In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: GE's management commitment, growth, and dividend yield are too enticing and offer a more powerful combination than any of the others in this sterling field.
The Motley Fool February 8, 2006 Stephen D. Simpson	A NICE Pile of Cash Growth is strong, but NICE is clearly looking for deals. It's still a relatively small company, so investors should make sure they can handle the chills, thrills, and spills that go with investing in smaller-cap technology ideas.
The Motley Fool February 8, 2006 John Bluis	Wrigley Says "Chew on This" While the P/E ratio looks extremely high for a company expected to grow only 11% for the next five years, the stock hasn't been a true bargain for quite a few decades.
The Motley Fool February 8, 2006 Stephen D. Simpson	Glaxo: Healthy Drugmaker Glaxo combines a huge sales force, a rich pipeline, and solid returns on capital. This company should get a thorough look from anyone putting new money into the pharma space.
The Motley Fool February 8, 2006 Alyce Lomax	Blue Nile Breaks Hearts Has the online diamond purveyor lost its luster? Investors, take note.
<Older 12311-12320 Newer> Return to current articles.